Cell line · CVCL_2989
KMS-11
Cancer cell line, Homo sapiens. Plasma cell myeloma. 52 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. KMS-11. Cell lines, record CVCL_2989. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2989
On this page
Cell line
As Cellosaurus gives it.
- Name
- KMS-11
- Accession
- CVCL_2989
- RRID
- RRID:CVCL_2989
- Synonyms
- KMS11, kms11, kms 11, Kawasaki Medical School-11
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 67Y
- Category
- Cancer cell line
- Diseases
- Plasma cell myeloma (NCIt C3242); Multiple myeloma (ORDO Orphanet_29073)
- Derived from
- Pleural effusion (in situ)
- Cell type
- Plasma cell
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers52
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Carrier-Free Berberine/Nitidine Chloride Self-Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer Susceptibility to Stapled Oncolytic Peptides Is Dictated by Membrane Cholesterol and Inflammatory Signaling. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Anti-myeloma activity of the CXCR4 antagonist WZ811. | J Mol Med (Berl) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting PRKCN, an Essential Driver Orchestrating mTOR-IRF4 Axis Independently of Kinase Activity, in Multiple Myeloma. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Therapeutic potential of PRMT1 as a critical survival dependency target in multiple myeloma. | BMC Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells. | PLoS Biol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28. | Biomark Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death. | Cell Rep | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 52
See all 52 papersRelatives6
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | KMS-11 WHSC1(+/-) | CVCL_HE02 | Cell lines | |
| Derived from it | KMS-11 WHSC1(trans/-) | CVCL_HE03 | Cell lines | |
| Derived from it | KMS-11/BR | CVCL_VJ34 | Cell lines | |
| Derived from it | KMS-11/BTZ | CVCL_4V71 | Cell lines | |
| Derived from it | KMS-11/Cfz | CVCL_IQ84 | Cell lines | |
| Derived from it | KMS-11R | CVCL_D705 | Cell lines |
Cell banks2
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| JCRB | JCRB1179 | JCRB | |
| JCRB | NIHS0482 | Discontinued | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2989
GET https://conductscience.org/api/cell-lines/v1/CVCL_2989/papers?page=2